5.33 USD
+0.03 (+0.57%)
ChartMill assigns a Buy % Consensus number of 78% to GBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.94. This target is 480.49% above the current price.
GBIO was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about GBIO.
In the previous month the buy percentage consensus was at a similar level.
GBIO was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-13 | Needham | Reiterate | Buy -> Buy |
| 2025-08-13 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-05-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-03-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-14 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2025-03-14 | Needham | Reiterate | Buy -> Buy |
| 2025-01-08 | Needham | Maintains | Buy -> Buy |
| 2024-10-23 | Needham | Reiterate | Buy -> Buy |
| 2024-08-08 | Needham | Reiterate | Buy -> Buy |
| 2024-08-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-14 | Needham | Reiterate | Buy -> Buy |
| 2024-05-14 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-07 | Needham | Maintains | Buy -> Buy |
| 2024-03-07 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-10-23 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2023-10-19 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-08-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-03 | Needham | Reiterate | Buy |
| 2023-08-03 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-11 | Needham | Reiterate | Buy -> Buy |
| 2023-04-19 | Needham | Reiterate | Buy |
| 2023-03-24 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-23 | Needham | Reiterate | Buy |
| 2023-03-06 | JMP Securities | Maintains | Market Outperform |
| 2023-02-24 | Needham | Maintains | Buy |
| 2023-01-19 | JMP Securities | Maintains | Market Outperform |
GENERATION BIO CO / GBIO FAQ
What do analysts expect the price target to be for GENERATION BIO CO (GBIO)?
12 analysts have analysed GBIO and the average price target is 30.94 USD. This implies a price increase of 480.49% is expected in the next year compared to the current price of 5.33.
What is the consensus rating for GBIO stock?
The consensus rating for GENERATION BIO CO (GBIO) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover GENERATION BIO CO (GBIO) stock?
The number of analysts covering GENERATION BIO CO (GBIO) is 12.